These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 30766778)

  • 1. The effects of pH, surfactant, ion concentration, coformer, and molecular arrangement on the solubility behavior of myricetin cocrystals.
    Ren S; Liu M; Hong C; Li G; Sun J; Wang J; Zhang L; Xie Y
    Acta Pharm Sin B; 2019 Jan; 9(1):59-73. PubMed ID: 30766778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel strategy for pharmaceutical cocrystal generation without knowledge of stoichiometric ratio: myricetin cocrystals and a ternary phase diagram.
    Hong C; Xie Y; Yao Y; Li G; Yuan X; Shen H
    Pharm Res; 2015 Jan; 32(1):47-60. PubMed ID: 24939640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaceutical characterisation and evaluation of cocrystals: Importance of in vitro dissolution conditions and type of coformer.
    Tomaszewska I; Karki S; Shur J; Price R; Fotaki N
    Int J Pharm; 2013 Sep; 453(2):380-8. PubMed ID: 23727143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Coformer Selection on In Vitro and In Vivo Performance of Adefovir Dipivoxil Cocrystals.
    Li L; Pang Z; Ma K; Gao Y; Zheng D; Wei Y; Zhang J; Qian S
    Pharm Res; 2021 Oct; 38(10):1777-1791. PubMed ID: 34729701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a pharmaceutical cocrystal with solution crystallization technology: Preparation, characterization, and evaluation of myricetin-proline cocrystals.
    Liu M; Hong C; Yao Y; Shen H; Ji G; Li G; Xie Y
    Eur J Pharm Biopharm; 2016 Oct; 107():151-9. PubMed ID: 27395394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Coformer and Polymer on Particle Surface Solution-Mediated Phase Transformation of Cocrystals in Aqueous Media.
    Omori M; Watanabe T; Uekusa T; Oki J; Inoue D; Sugano K
    Mol Pharm; 2020 Oct; 17(10):3825-3836. PubMed ID: 32870691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superior Solubility and Dissolution of Zaltoprofen via Pharmaceutical Cocrystals.
    Panzade P; Shendarkar G
    Turk J Pharm Sci; 2019 Sep; 16(3):310-316. PubMed ID: 32454729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving Dissolution Rate of Carbamazepine-Glutaric Acid Cocrystal Through Solubilization by Excess Coformer.
    Yamashita H; Sun CC
    Pharm Res; 2017 Dec; 35(1):4. PubMed ID: 29288433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Competitive cocrystallization and its application in the separation of flavonoids.
    Xia Y; Wei Y; Chen H; Qian S; Zhang J; Gao Y
    IUCrJ; 2021 Mar; 8(Pt 2):195-207. PubMed ID: 33708397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of Coformer Stoichiometric Ratio on Pharmaceutical Cocrystal Dissolution: Three Cocrystals of Carbamazepine/4-Aminobenzoic Acid.
    Li Z; Matzger AJ
    Mol Pharm; 2016 Mar; 13(3):990-5. PubMed ID: 26837376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-drug cocrystals of antituberculous 4-aminosalicylic acid: Screening, crystal structures, thermochemical and solubility studies.
    Drozd KV; Manin AN; Churakov AV; Perlovich GL
    Eur J Pharm Sci; 2017 Mar; 99():228-239. PubMed ID: 28011126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid State Characterization and Dissolution Enhancement of Nevirapine Cocrystals.
    Panzade P; Shendarkar G; Kulkarni D; Shelke S
    Adv Pharm Bull; 2021 Sep; 11(4):772-776. PubMed ID: 34888225
    [No Abstract]   [Full Text] [Related]  

  • 13. Cocrystal solubility product analysis - Dual concentration-pH mass action model not dependent on explicit solubility equations.
    Avdeef A
    Eur J Pharm Sci; 2017 Dec; 110():2-18. PubMed ID: 28392495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering cocrystal solubility, stability, and pH(max) by micellar solubilization.
    Huang N; Rodríguez-Hornedo N
    J Pharm Sci; 2011 Dec; 100(12):5219-34. PubMed ID: 21910122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel furosemide cocrystals and selection of high solubility drug forms.
    Goud NR; Gangavaram S; Suresh K; Pal S; Manjunatha SG; Nambiar S; Nangia A
    J Pharm Sci; 2012 Feb; 101(2):664-80. PubMed ID: 22081478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isostructural cocrystals of metaxalone with improved dissolution characteristics.
    Gohel SK; Palanisamy V; Sanphui P; Prakash M; Singh GP; Chernyshev V
    RSC Adv; 2021 Sep; 11(49):30689-30700. PubMed ID: 35479860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmaceutical Cocrystal of Piroxicam: Design, Formulation and Evaluation.
    Panzade P; Shendarkar G; Shaikh S; Balmukund Rathi P
    Adv Pharm Bull; 2017 Sep; 7(3):399-408. PubMed ID: 29071222
    [No Abstract]   [Full Text] [Related]  

  • 18. Nanoconfinement of a Pharmaceutical Cocrystal with Praziquantel in Mesoporous Silica: The Influence of the Solid Form on Dissolution Enhancement.
    Salas-Zúñiga R; Mondragón-Vásquez K; Alcalá-Alcalá S; Lima E; Höpfl H; Herrera-Ruiz D; Morales-Rojas H
    Mol Pharm; 2022 Feb; 19(2):414-431. PubMed ID: 34967632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of possible solubility and dissolution advantages of cocrystals, I: Aqueous solubility and dissolution rates of ketoconazole and its cocrystals as functions of pH.
    Vasoya JM; Shah AV; Serajuddin ATM
    ADMET DMPK; 2019; 7(2):106-130. PubMed ID: 35350544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Creation of Hydrochlorothiazide Pharmaceutical Cocrystals Via Hot-Melt Extrusion for Enhanced Solubility and Permeability.
    Narala S; Nyavanandi D; Alzahrani A; Bandari S; Zhang F; Repka MA
    AAPS PharmSciTech; 2022 Jan; 23(1):56. PubMed ID: 35043282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.